Skip to main navigation Skip to search Skip to main content

The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study

  • Karen L. Kotloff
  • , William C. Blackwelder
  • , Dilruba Nasrin
  • , James P. Nataro
  • , Tamer H. Farag
  • , Anna Van Eijk
  • , Richard A. Adegbola
  • , Pedro L. Alonso
  • , Robert F. Breiman
  • , Abu Syed Golam Faruque
  • , Debasish Saha
  • , Samba O. Sow
  • , Dipika Sur
  • , Anita K.M. Zaidi
  • , Kousick Biswas
  • , Sandra Panchalingam
  • , John D. Clemens
  • , Dani Cohen
  • , Roger I. Glass
  • , Eric D. Mintz
  • Halvor Sommerfelt, Myron M. Levine
  • University of Maryland, Baltimore
  • University of Virginia
  • Medical Research Council (United Kingdom) Unit
  • GlaxoSmithKline
  • University of Barcelona
  • Centro de investigação de Saúde de Manhiça
  • Centers for Disease Control and Prevention
  • International Centre for Diarrhoeal Disease Research Bangladesh
  • Centre pour le Développement des Vaccins
  • National Institute of Cholera and Enteric Diseases India
  • Aga Khan University
  • Department of Veterans Affairs
  • International Vaccine Institute, Seoul
  • University of California at Los Angeles
  • Tel Aviv University
  • National Institutes of Health
  • University of Bergen
  • Norwegian Institute of Public Health

Research output: Contribution to journalArticlepeer-review

313 Citations (Scopus)

Abstract

Background. 

Diarrhea is a leading cause of illness and death among children aged <5 years in developing countries. This paper describes the clinical and epidemiological methods used to conduct the Global Enteric Multicenter Study (GEMS), a 3-year, prospective, age-stratified, case/control study to estimate the population-based burden, microbiologic etiology, and adverse clinical consequences of acute moderate-to-severe diarrhea (MSD) among a censused population of children aged 0–59 months seeking care at health centers in sub-Saharan Africa and South Asia.

Methods. 

GEMS was conducted at 7 field sites, each serving a population whose demography and healthcare utilization practices for childhood diarrhea were documented. We aimed to enroll 220 MSD cases per year from selected health centers serving each site in each of 3 age strata (0–11, 12–23, and 24–59 months), along with 1–3 matched community controls. Cases and controls supplied clinical, epidemiologic, and anthropometric data at enrollment and again approximately 60 days later, and provided enrollment stool specimens for identification and characterization of potential diarrheal pathogens. Verbal autopsy was performed if a child died. Analytic strategies will calculate the fraction of MSD attributable to each pathogen and the incidence, financial costs, nutritional consequences, and case fatality overall and by pathogen.

Conclusions. 

When completed, GEMS will provide estimates of the incidence, etiology, and outcomes of MSD among infants and young children in sub-Saharan Africa and South Asia. This information can guide development and implementation of public health interventions to diminish morbidity and mortality from diarrheal diseases.

Original languageEnglish
Pages (from-to)S232-S245
JournalClinical Infectious Diseases
Volume55
Issue numberSUPPL. 4
DOIs
Publication statusPublished - 15 Dec 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study'. Together they form a unique fingerprint.

Cite this